Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,821 to 1,840 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| TRAJ60 T cell receptor alpha joining 60 (pseudogene) | 28695 HGNC:12093 | 0 | 0 | 0 | 0 | 2,845 | 3,708 |
| ACP3 acid phosphatase 3 | 55 HGNC:125 | 1 | 117 | 1 | 34 | 1,290 | 3,704 |
| FLNC filamin C | 2318 HGNC:3756 | 1 | 34 | 0 | 0 | 2,170 | 3,704 |
| GLI3 GLI family zinc finger 3 | 2737 HGNC:4319 | 1 | 35 | 0 | 0 | 2,274 | 3,698 |
| TFF1 trefoil factor 1 | 7031 HGNC:11755 | 1 | 106 | 0 | 0 | 1,959 | 3,695 |
| IFIT2 interferon induced protein with tetratricopeptide repeats 2 | 3433 HGNC:5409 | 1 | 21 | 0 | 0 | 2,804 | 3,694 |
| SYN1 synapsin I | 6853 HGNC:11494 | 1 | 20 | 0 | 0 | 3,319 | 3,694 |
| CBFB core-binding factor subunit beta | 865 HGNC:1539 | 1 | 33 | 0 | 0 | 1,808 | 3,690 |
| IL33R interleukin 33 receptor | 9173 HGNC:5998 | 1 | 120 | 1 | 6 | 2,721 | 3,690 |
| SFTPB surfactant protein B | 6439 HGNC:10801 | 1 | 75 | 0 | 0 | 2,156 | 3,679 |
| NECTIN1 nectin cell adhesion molecule 1 | 5818 HGNC:9706 | 1 | 51 | 0 | 0 | 2,464 | 3,675 |
| RAD51C RAD51 paralog C | 5889 HGNC:9820 | 1 | 26 | 0 | 0 | 1,650 | 3,668 |
| IGF2BP2 insulin like growth factor 2 mRNA binding protein 2 | 10644 HGNC:28867 | 1 | 27 | 0 | 0 | 1,711 | 3,666 |
| CD244 CD244 molecule | 51744 HGNC:18171 | 1 | 102 | 0 | 0 | 2,389 | 3,665 |
| FGF4 fibroblast growth factor 4 | 2249 HGNC:3682 | 1 | 165 | 0 | 0 | 2,054 | 3,660 |
| CASP6 caspase 6 | 839 HGNC:1507 | 1 | 75 | 1 | 11 | 1,719 | 3,659 |
| SIN3A SIN3 transcription regulator family member A | 25942 HGNC:19353 | 1 | 25 | 0 | 0 | 2,893 | 3,655 |
| FGA fibrinogen alpha chain | 2243 HGNC:3661 | 1 | 136 | 5 | 40 | 1,534 | 3,650 |
| HSD11B2 hydroxysteroid 11-beta dehydrogenase 2 | 3291 HGNC:5209 | 1 | 15 | 1 | 0 | 1,755 | 3,649 |
| MIR27B microRNA 27b | 407019 HGNC:31614 | 0 | 0 | 0 | 0 | 1,374 | 3,646 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=92
{
"data": {
"total": 193990,
"results": [
{
"id": "28695",
"title": "TRAJ60: T cell receptor alpha joining 60 (pseudogene)",
"summary": "NCBI Gene 28695. 0 proteins, 0 patents, 0 drugs, 0 trials, 2,845 NIH grants and 3,708 papers.",
"record": "/library/genes/28695",
"gene_id": 28695,
"symbol": "TRAJ60",
"name": "T cell receptor alpha joining 60 (pseudogene)",
"hgnc_id": "HGNC:12093",
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 2845,
"papers": 3708
}
},
{
"id": "55",
"title": "ACP3: acid phosphatase 3",
"summary": "NCBI Gene 55. 1 protein, 117 patents, 1 drug, 34 trials, 1,290 NIH grants and 3,704 papers.",
"record": "/library/genes/55",
"gene_id": 55,
"symbol": "ACP3",
"name": "acid phosphatase 3",
"hgnc_id": "HGNC:125",
"counts": {
"proteins": 1,
"patents": 117,
"drugs": 1,
"trials": 34,
"grants": 1290,
"papers": 3704
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=93",
"request_id": "VTZ8cRUDM8djqE8Y"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant